Preventing transmission of multidrug-resistant bacteria in health care settings: A tale of two guidelines

Larry J. Strausbaugh, Jane D. Siegel, Robert A. Weinstein

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Two guidelines for the control of multidrug-resistant organisms in health care facilities have appeared during the past 3 years-one from the Society for Healthcare Epidemiology of America and one, in draft form, from the Healthcare Infection Control Practices Advisory Committee of the Centers for Disease Control and Prevention. These guidelines reflect universal concern in the infection-control community about today's unprecedented levels of activity of multidrug-resistant organisms and about inadequate or inconsistent application of potentially effective control measures. The 2 guidelines provide detailed reviews of pertinent issues and evidence-based, rated recommendations, which overlap considerably. Recommendations regarding indications for active surveillance cultures and the extent of their use constitute the major divergence. Although implementation of comprehensive control plans for multidrug-resistant organisms advocated by both guidelines will require health care facilities to confront difficult programmatic issues, aggressive and widespread adoption of control measures for multidrug-resistant organisms is urgently needed.

Original languageEnglish (US)
Pages (from-to)828-835
Number of pages8
JournalClinical Infectious Diseases
Volume42
Issue number6
DOIs
StatePublished - Mar 15 2006

Fingerprint

Guidelines
Bacteria
Delivery of Health Care
Health Facilities
Infection Control
Advisory Committees
Centers for Disease Control and Prevention (U.S.)

ASJC Scopus subject areas

  • Immunology

Cite this

Preventing transmission of multidrug-resistant bacteria in health care settings : A tale of two guidelines. / Strausbaugh, Larry J.; Siegel, Jane D.; Weinstein, Robert A.

In: Clinical Infectious Diseases, Vol. 42, No. 6, 15.03.2006, p. 828-835.

Research output: Contribution to journalArticle

Strausbaugh, Larry J. ; Siegel, Jane D. ; Weinstein, Robert A. / Preventing transmission of multidrug-resistant bacteria in health care settings : A tale of two guidelines. In: Clinical Infectious Diseases. 2006 ; Vol. 42, No. 6. pp. 828-835.
@article{474a4fc3e5ae4f559ef1bfa78121d9e3,
title = "Preventing transmission of multidrug-resistant bacteria in health care settings: A tale of two guidelines",
abstract = "Two guidelines for the control of multidrug-resistant organisms in health care facilities have appeared during the past 3 years-one from the Society for Healthcare Epidemiology of America and one, in draft form, from the Healthcare Infection Control Practices Advisory Committee of the Centers for Disease Control and Prevention. These guidelines reflect universal concern in the infection-control community about today's unprecedented levels of activity of multidrug-resistant organisms and about inadequate or inconsistent application of potentially effective control measures. The 2 guidelines provide detailed reviews of pertinent issues and evidence-based, rated recommendations, which overlap considerably. Recommendations regarding indications for active surveillance cultures and the extent of their use constitute the major divergence. Although implementation of comprehensive control plans for multidrug-resistant organisms advocated by both guidelines will require health care facilities to confront difficult programmatic issues, aggressive and widespread adoption of control measures for multidrug-resistant organisms is urgently needed.",
author = "Strausbaugh, {Larry J.} and Siegel, {Jane D.} and Weinstein, {Robert A.}",
year = "2006",
month = "3",
day = "15",
doi = "10.1086/500408",
language = "English (US)",
volume = "42",
pages = "828--835",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Preventing transmission of multidrug-resistant bacteria in health care settings

T2 - A tale of two guidelines

AU - Strausbaugh, Larry J.

AU - Siegel, Jane D.

AU - Weinstein, Robert A.

PY - 2006/3/15

Y1 - 2006/3/15

N2 - Two guidelines for the control of multidrug-resistant organisms in health care facilities have appeared during the past 3 years-one from the Society for Healthcare Epidemiology of America and one, in draft form, from the Healthcare Infection Control Practices Advisory Committee of the Centers for Disease Control and Prevention. These guidelines reflect universal concern in the infection-control community about today's unprecedented levels of activity of multidrug-resistant organisms and about inadequate or inconsistent application of potentially effective control measures. The 2 guidelines provide detailed reviews of pertinent issues and evidence-based, rated recommendations, which overlap considerably. Recommendations regarding indications for active surveillance cultures and the extent of their use constitute the major divergence. Although implementation of comprehensive control plans for multidrug-resistant organisms advocated by both guidelines will require health care facilities to confront difficult programmatic issues, aggressive and widespread adoption of control measures for multidrug-resistant organisms is urgently needed.

AB - Two guidelines for the control of multidrug-resistant organisms in health care facilities have appeared during the past 3 years-one from the Society for Healthcare Epidemiology of America and one, in draft form, from the Healthcare Infection Control Practices Advisory Committee of the Centers for Disease Control and Prevention. These guidelines reflect universal concern in the infection-control community about today's unprecedented levels of activity of multidrug-resistant organisms and about inadequate or inconsistent application of potentially effective control measures. The 2 guidelines provide detailed reviews of pertinent issues and evidence-based, rated recommendations, which overlap considerably. Recommendations regarding indications for active surveillance cultures and the extent of their use constitute the major divergence. Although implementation of comprehensive control plans for multidrug-resistant organisms advocated by both guidelines will require health care facilities to confront difficult programmatic issues, aggressive and widespread adoption of control measures for multidrug-resistant organisms is urgently needed.

UR - http://www.scopus.com/inward/record.url?scp=33644836125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644836125&partnerID=8YFLogxK

U2 - 10.1086/500408

DO - 10.1086/500408

M3 - Article

C2 - 16477561

AN - SCOPUS:33644836125

VL - 42

SP - 828

EP - 835

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 6

ER -